Enhanced cannabis timeline followback (EC-TLFB) : Comprehensive assessment of cannabis use including standard THC units and validation through biological measures
© 2023 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction..
AIMS: The aims of this study were to present an enhanced cannabis timeline followback (EC-TLFB) enabling comprehensive assessment of cannabis use measures, including standard tetrahydrocannabinol (THC) units, and to validate these against objectively indexed urinary 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) concentrations.
DESIGN: We used cross-sectional baseline data from the 'CannTeen' observational longitudinal study.
SETTING: The study was conducted in London, UK.
PARTICIPANTS: A total of 147 participants who used cannabis regularly took part in the study (n = 71 female, n = 76 male; mean age = 21.90, standard deviation = 5.32).
MEASUREMENTS: The EC-TLFB was used to calculate frequency of cannabis use, method of administration, including co-administration with tobacco, amount of cannabis used (measured with unaided self-report and also using pictorial aided self-report) and type of cannabis product (flower, hash) which was used to estimate THC concentration (both from published data on THC concentration of products and analysis of cannabis samples donated by participants in this study). We calculated total weekly standard THC units (i.e. 5 mg THC for all cannabis products and methods of administration) using the EC-TLFB. The outcome variable for validation of past week EC-TLFB assessments was creatinine-normalized carboxy-tetrahydrocannabinol (THC-COOH) in urine.
FINDINGS: All measures of cannabis exposure included in this analysis were positively correlated with levels of THC-COOH in urine (r = 0.41-0.52). Standard THC units, calculated with average concentrations of THC in cannabis in the UK and unaided self-report measures of amount of cannabis used in grams showed the strongest correlation with THC-COOH in urine (r = 0.52, 95% bias-corrected and accelerated = 0.26-0.70).
CONCLUSIONS: The enhanced cannabis timeline followback (EC-TLFB) can provide a valid assessment of a comprehensive set of cannabis use measures including standard tetrahydrocannabinol units as well as and traditional TLFB assessments (e.g. frequency of use and grams of cannabis use).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
|---|---|
| Enthalten in: |
Addiction (Abingdon, England) - 119(2024), 4 vom: 01. März, Seite 772-783 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Petrilli, Kat [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7J8897W37S |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/add.16405 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365957313 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365957313 | ||
| 003 | DE-627 | ||
| 005 | 20240314234744.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/add.16405 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1328.xml |
| 035 | |a (DE-627)NLM365957313 | ||
| 035 | |a (NLM)38105033 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Petrilli, Kat |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced cannabis timeline followback (EC-TLFB) |b Comprehensive assessment of cannabis use including standard THC units and validation through biological measures |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. | ||
| 520 | |a AIMS: The aims of this study were to present an enhanced cannabis timeline followback (EC-TLFB) enabling comprehensive assessment of cannabis use measures, including standard tetrahydrocannabinol (THC) units, and to validate these against objectively indexed urinary 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) concentrations | ||
| 520 | |a DESIGN: We used cross-sectional baseline data from the 'CannTeen' observational longitudinal study | ||
| 520 | |a SETTING: The study was conducted in London, UK | ||
| 520 | |a PARTICIPANTS: A total of 147 participants who used cannabis regularly took part in the study (n = 71 female, n = 76 male; mean age = 21.90, standard deviation = 5.32) | ||
| 520 | |a MEASUREMENTS: The EC-TLFB was used to calculate frequency of cannabis use, method of administration, including co-administration with tobacco, amount of cannabis used (measured with unaided self-report and also using pictorial aided self-report) and type of cannabis product (flower, hash) which was used to estimate THC concentration (both from published data on THC concentration of products and analysis of cannabis samples donated by participants in this study). We calculated total weekly standard THC units (i.e. 5 mg THC for all cannabis products and methods of administration) using the EC-TLFB. The outcome variable for validation of past week EC-TLFB assessments was creatinine-normalized carboxy-tetrahydrocannabinol (THC-COOH) in urine | ||
| 520 | |a FINDINGS: All measures of cannabis exposure included in this analysis were positively correlated with levels of THC-COOH in urine (r = 0.41-0.52). Standard THC units, calculated with average concentrations of THC in cannabis in the UK and unaided self-report measures of amount of cannabis used in grams showed the strongest correlation with THC-COOH in urine (r = 0.52, 95% bias-corrected and accelerated = 0.26-0.70) | ||
| 520 | |a CONCLUSIONS: The enhanced cannabis timeline followback (EC-TLFB) can provide a valid assessment of a comprehensive set of cannabis use measures including standard tetrahydrocannabinol units as well as and traditional TLFB assessments (e.g. frequency of use and grams of cannabis use) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Assessment | |
| 650 | 4 | |a EC-TLFB | |
| 650 | 4 | |a cannabis | |
| 650 | 4 | |a dose | |
| 650 | 4 | |a measurement | |
| 650 | 4 | |a standardization | |
| 650 | 7 | |a Cannabinoid Receptor Agonists |2 NLM | |
| 650 | 7 | |a Dronabinol |2 NLM | |
| 650 | 7 | |a 7J8897W37S |2 NLM | |
| 650 | 7 | |a Hallucinogens |2 NLM | |
| 700 | 1 | |a Lawn, Will |e verfasserin |4 aut | |
| 700 | 1 | |a Lees, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Mokrysz, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Borissova, Anya |e verfasserin |4 aut | |
| 700 | 1 | |a Ofori, Shelan |e verfasserin |4 aut | |
| 700 | 1 | |a Trinci, Katie |e verfasserin |4 aut | |
| 700 | 1 | |a Dos Santos, Renato |e verfasserin |4 aut | |
| 700 | 1 | |a Leitch, Harry |e verfasserin |4 aut | |
| 700 | 1 | |a Soni, Shilpa |e verfasserin |4 aut | |
| 700 | 1 | |a Hines, Lindsey A |e verfasserin |4 aut | |
| 700 | 1 | |a Lorenzetti, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Curran, H Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Freeman, Tom P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Addiction (Abingdon, England) |d 1993 |g 119(2024), 4 vom: 01. März, Seite 772-783 |w (DE-627)NLM075102978 |x 1360-0443 |7 nnns |
| 773 | 1 | 8 | |g volume:119 |g year:2024 |g number:4 |g day:01 |g month:03 |g pages:772-783 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/add.16405 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 119 |j 2024 |e 4 |b 01 |c 03 |h 772-783 | ||